TAK 4%: long-term decline

https://www.tradingview.com/symbols/NYSE-TAK/ shows long-term decline since 2008. This is another case study of long-term decline, comparable to LFC and IMBBY

  • πŸ™‚ 4% CDY. Increased through 2020. https://www.nasdaq.com/market-activity/stocks/tak/dividend-history
  • https://money.usnews.com/investing/dividends/slideshows/best-pharmaceutical-stocks-to-buy-for-income?slide=9
  • 60B. based in Japan, biggest pharma in Asia.. good diversification
  • πŸ™‚ analysts positive.. target price mid Apr $23

UOVEY 4% #UOB

  • available as UOVEY on OTC, not as liquid as on SGX
  • πŸ™‚ dividend maintained through 2020 ..CDY 4% .. https://www.morningstar.com/stocks/pinx/uovey/dividends shows CDY, DPR
  • .. https://seekingalpha.com/symbol/UOVEY/dividends/history shows div + price chart
  • reasonable quantumΒ 
  • πŸ™‚ analysts positive .. tgt $50 https://money.cnn.com/quote/forecast/forecast.html?symb=UOVEY
  • 12M good: reverse-V

143>CVX: comparable to XOM #wanted $150; achieved

Chevron, one of the 6 oil majors, has a market cap comparable to XOM.

  • πŸ‘ŽΒ 12M high up.
  • πŸ™‚ div increased through 2020. CDY 6% .. https://www.nasdaq.com/market-activity/stocks/cvx/dividend-history
  • analyst no sell. tgt $143 https://www.tipranks.com/stocks/cvx/forecast
  • πŸ™‚ part of the aristocrats
  • πŸ™‚ I already bought one share

National Grid of UK 4%

  • 40B established, part of the FTSE 100.Β probably a monopoly.Β millions of gas customers and millions of electricity customers.
  • dividend maintained through 2020, but unstable. CDY 4% https://www.nasdaq.com/market-activity/stocks/ngg/dividend-history
  • πŸ™‚ 3/12M chart not recovered yet
  • πŸ™‚ analysts positive

ARCC+HTGC financiers: #high DYOC #$40 each

both unknown investment firms, small quantum.

— infatuation ..Β For both, the analysts and pre-trade tcost build up pressure on me to Buy immediately, but price up trend is unfavorable, so it’s safer to cool down and use conservative limit orders.

— ARCC

  • 3M chart is up; 12M chart: almost recovered
  • πŸ™‚ I bought early, so no hurry to top-up. No infatuation please.
  • πŸ™‚ div maintained through 2020. CDY 9%. https://www.nasdaq.com/market-activity/stocks/arcc/dividend-history
  • πŸ™‚ analysts highly positive
  • 7B market cap

— HTGC #Hercules

  • 3M chart is up; 12M chart: almost recovered
  • πŸ™‚ I bought early, so no hurry to top-up. No infatuation please.
  • πŸ™‚ div maintained through 2020. CDY 8%. https://www.nasdaq.com/market-activity/stocks/htgc/dividend-history
  • πŸ™‚ analyst 100%

PFE: 3% div blue-chip #$300

  • analysts: no Sell
  • πŸ™‚ price trend: 3M down
  • πŸ™‚ div no cut for years. CDY 4%, above average among blue chips.. https://www.nasdaq.com/market-activity/stocks/pfe/dividend-history
  • overvalued? Less so than tech stocks
  • πŸ™‚ 5Y history is fairly stable
  • πŸ™‚ no worrying signs
  • πŸ™‚ compared to MRNA — more established, less hyped

— perception:

  • πŸ™‚ perception: large, established
  • πŸ™‚ mature sector, not sunset sector, not under threat

But every stock in this category can be overvalued. Analog: You can worry about every college you are applying “It may lose its prestige after I enroll.”

— compared to other blue chips

  • more stable than motor, oil sectors, flight/cruise, GE,
  • comparable to industrial, financial
  • any other blue chip to consider?